Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

Summary

This clinical study will be a prospective, placebo-controlled, double-blind, randomized and centrally evaluated intra-individual comparative study to assess the safety and efficacy of AR/101 concomitantly administered with Standard of Care (SoC) in accelerating re epithelialization of split thickness wounds compared with placebo and concomitantly with SoC, in the pannus of volunteers undergoing elective abdominoplasty.

Timeline

Start

2015-11

Primary completion

2017-06

Completion

2017-06

Drugs

Indications

No indication recorded.